title: SDF-1α and LPA modulate microglia potassium channels through rho gtpases to regulate cell morphology.
abstract: Microglia are the resident immune cells of the brain, which are important therapeutic targets for regulating the inflammatory responses particularly neurodegeneration in the aging human brain. The activation, chemotaxis and migration of microglia are regulated through G-protein coupled receptors by chemokines such as stromal cell-derived factor (SDF)-1α and bioactive lysophospholipids such as lysophosphatidic acid (LPA). Potassium channels play important roles in microglial function and cell fate decisions; however, the regulation of microglial potassium channels has not been fully elucidated. Here we show reciprocal action of SDF-1α and LPA, on potassium currents through Kir2.1 channels in primary murine microglia. The potassium channel modulation is mediated by the same small GTPases, Rac and Rho that regulate the actin cytoskeleton. SDF-1α rapidly increased the Kir2.1 current amplitude and cell spreading. These effects were mimicked by dialysing the cells with constitutively active Rac1 protein, and they were blocked by inhibiting the phosphatidylinositol 3-kinase (PI3K) with wortmannin. In contrast, LPA and constitutively active RhoA decreased the Kir2.1 currents and stimulated cell contraction. Thus, SDF-1α and LPA regulate both the actin cytoskeleton and the Kir2.1 potassium channels through the same Rho GTPase signaling pathways. The inhibition of Kir2.1 with chloroethylclonidine produced cell contraction independently of chemokine action. This suggests that potassium channels are essential for the morphological phenotype and functioning of microglia. In conclusion, the small GTPases, Rac and Rho, modulate Kir2.1 channels and block of Kir2.1 channels causes changes in microglia morphology.
authors.affiliation: Laboratory of Neurobiology, NIEHS/NIH, Research Triangle Park, North Carolina, USA.
authors.forename: Michelle J
authors.initials: MJ
authors.lastname: Muessel
authors.forename: G Jean
authors.initials: GJ
authors.lastname: Harry
authors.forename: David L
authors.initials: DL
authors.lastname: Armstrong
authors.forename: Nina M
authors.initials: NM
authors.lastname: Storey
mesh_terms: D008841:Actin Cytoskeleton / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D000943:Antigens, Differentiation / Q000378:metabolism; D048429:Cell Size / Q000187:drug effects; D002540:Cerebral Cortex / Q000166:cytology; D054377:Chemokine CXCL12 / Q000494:pharmacology*; D003000:Clonidine / Q000031:analogs & derivatives / Q000494:pharmacology; D008246:Lysophospholipids / Q000494:pharmacology*; D051379:Mice; D017628:Microglia / Q000187:drug effects* / Q000378:metabolism*; D018613:Microscopy, Confocal; D018408:Patch-Clamp Techniques; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024661:Potassium Channels, Inwardly Rectifying / Q000502:physiology*; D021381:Protein Transport / Q000187:drug effects / Q000235:genetics; D019718:Receptors, CXCR4 / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics; D014162:Transfection; D020830:rac1 GTP-Binding Protein / Q000378:metabolism; D020741:rho GTP-Binding Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D000943:Antigens, Differentiation; C514936:CXCR4 protein, mouse; D054377:Chemokine CXCL12; C489461:Kir2.1 channel; D008246:Lysophospholipids; D026902:Potassium Channel Blockers; D024661:Potassium Channels, Inwardly Rectifying; D019718:Receptors, CXCR4; C036763:monocyte-macrophage differentiation antigen; C051731:chlorethylclonidine; D019869:Phosphatidylinositol 3-Kinases; D020830:rac1 GTP-Binding Protein; D020741:rho GTP-Binding Proteins; D003000:Clonidine; C032881:lysophosphatidic acid
keywords: PI3-kinase; Rho GTPases; microglia; potassium channel
references.citation: Biochem Biophys Res Commun. 2008 Jun 27;371(2):283-8
references.pmid: 18435916
references.citation: J Neurosci. 2012 Dec 5;32(49):17725-39
references.pmid: 23223293
references.citation: Glia. 2012 May;60(5):761-70
references.pmid: 22331560
references.citation: J Cell Sci. 2008 Mar 1;121(Pt 5):551-9
references.pmid: 18287584
references.citation: Neuroscience. 2002;109(4):827-35
references.pmid: 11927165
references.citation: PLoS One. 2012;7(5):e37163
references.pmid: 22623989
references.citation: J Neurosci. 1993 Oct;13(10):4403-11
references.pmid: 7692013
references.citation: Blood. 2011 Dec 1;118(23):6164-71
references.pmid: 21976675
references.citation: Biochem J. 2007 Jan 15;401(2):377-90
references.pmid: 17173542
references.citation: Nat Rev Mol Cell Biol. 2008 Nov;9(11):846-59
references.pmid: 18946474
references.citation: Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):7970-5
references.pmid: 18524949
references.citation: Neurotox Res. 2009 Oct;16(3):318-28
references.pmid: 19551455
references.citation: EMBO J. 2010 Aug 18;29(16):2734-45
references.pmid: 20717143
references.citation: Biochim Biophys Acta. 2013 Jan;1831(1):213-22
references.pmid: 22986288
references.citation: J Physiol. 2005 Sep 15;567(Pt 3):869-90
references.pmid: 16020460
references.citation: Exp Neurol. 2012 Apr;234(2):302-15
references.pmid: 21985863
references.citation: Immunol Lett. 2008 Jan 29;115(2):75-82
references.pmid: 18054087
references.citation: J Biol Chem. 2003 Oct 24;278(43):41988-97
references.pmid: 12923176
references.citation: Physiol Rev. 2012 Oct;92(4):1865-913
references.pmid: 23073633
references.citation: Glia. 2003 Apr 15;42(2):139-48
references.pmid: 12655598
references.citation: J Cell Physiol. 2011 Dec;226(12):3295-302
references.pmid: 21321937
references.citation: FEBS Lett. 2011 Dec 1;585(23):3798-805
references.pmid: 21889505
references.citation: J Cell Physiol. 2009 Feb;218(2):385-93
references.pmid: 18932198
references.citation: J Biol Chem. 2003 Oct 31;278(44):42867-76
references.pmid: 12904301
references.citation: FEBS Lett. 2003 Jul 3;546(1):93-7
references.pmid: 12829242
references.citation: J Cell Sci. 2007 Oct 15;120(Pt 20):3491-9
references.pmid: 17928305
references.citation: Dev Biol. 2004 Jan 1;265(1):23-32
references.pmid: 14697350
references.citation: Mol Pharmacol. 2003 Oct;64(4):987-93
references.pmid: 14500755
references.citation: Physiol Rev. 2011 Apr;91(2):461-553
references.pmid: 21527731
references.citation: Brain Res. 2007 Dec;1186:21-8
references.pmid: 18005942
references.citation: Br J Pharmacol. 1999 Oct;128(3):760-6
references.pmid: 10516659
references.citation: Cell. 2011 Jun 24;145(7):1012-22
references.pmid: 21703446
references.citation: Am J Physiol Cell Physiol. 2012 Sep 15;303(6):C666-72
references.pmid: 22875786
references.citation: Biophys J. 2012 Sep 19;103(6):1170-8
references.pmid: 22995489
references.citation: Curr Biol. 2002 Jan 8;12(1):27-33
references.pmid: 11790300
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5197-201
references.pmid: 16549781
references.citation: Am J Respir Cell Mol Biol. 2011 Nov;45(5):962-8
references.pmid: 21493782
references.citation: Neurotoxicology. 2012 Mar;33(2):191-206
references.pmid: 22322212
references.citation: Glia. 1993 Jan;7(1):93-101
references.pmid: 7678582
references.citation: J Cell Biol. 2001 May 14;153(4):677-86
references.pmid: 11352930
references.citation: Am J Physiol Cell Physiol. 2010 Jun;298(6):C1376-87
references.pmid: 20237148
references.citation: Proteomics. 2010 Jan;10(1):141-58
references.pmid: 19899077
references.citation: Nat Cell Biol. 2006 Aug;8(8):803-14
references.pmid: 16862148
references.citation: FEBS Lett. 2008 Jun 18;582(14):2075-85
references.pmid: 18452713
references.citation: Biol Cell. 2009 Jan;101(1):13-29
references.pmid: 19055486
references.citation: Trends Cell Biol. 2011 Dec;21(12):718-26
references.pmid: 21924908
references.citation: Cytoskeleton (Hoboken). 2010 Sep;67(9):545-54
references.pmid: 20803696
references.citation: FASEB J. 2012 Aug;26(8):3103-17
references.pmid: 22516295